Found: 16
Select item for more details and to access through your institution.
Improving genetic testing pathways for transthyretin amyloidosis in France: challenges and strategies.
- Published in:
- 2024
- By:
- Publication type:
- Letter
AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"?
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 11, p. 1, doi. 10.1111/ijcp.14817
- By:
- Publication type:
- Article
challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response.
- Published in:
- European Heart Journal, 2022, v. 43, n. 45, p. 4736, doi. 10.1093/eurheartj/ehac526
- By:
- Publication type:
- Article
Les amyloses cardiaques.
- Published in:
- Cahiers Santé - Médecine Thérapeutique, 2022, v. 31, n. 2, p. 117, doi. 10.1684/sanmt.2022.143
- By:
- Publication type:
- Article
Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 4888, doi. 10.3390/jcm10214888
- By:
- Publication type:
- Article
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 4868, doi. 10.3390/jcm10214868
- By:
- Publication type:
- Article
Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3415, doi. 10.3390/jcm10153415
- By:
- Publication type:
- Article
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257189
- By:
- Publication type:
- Article
Natural history and impact of treatment with tafamidis on major cardiovascular outcome‐free survival time in a cohort of patients with transthyretin amyloidosis.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 264, doi. 10.1002/ejhf.2028
- By:
- Publication type:
- Article
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 3, p. 1707, doi. 10.1002/ehf2.14671
- By:
- Publication type:
- Article
Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 5, p. 3556, doi. 10.1002/ehf2.14082
- By:
- Publication type:
- Article
Prevalence and determinants of iron deficiency in cardiac amyloidosis.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 2, p. 1314, doi. 10.1002/ehf2.13818
- By:
- Publication type:
- Article
Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1656, doi. 10.1002/ehf2.13131
- By:
- Publication type:
- Article
Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 13, p. 1, doi. 10.1161/JAHA.124.034723
- By:
- Publication type:
- Article
Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2396, doi. 10.1007/s00259-020-04753-7
- By:
- Publication type:
- Article
Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 828, doi. 10.1002/jha2.516
- By:
- Publication type:
- Article